C-Myc Drives Breast Cancer Metastasis to the Brain, but Promotes Synthetic Lethality With TRAIL.

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-18-0630
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

IGH/MYC Translocation Associates With BRCA2 Deficiency and Synthetic Lethality to PARP1 Inhibitors

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2017English

E-Cadherin/Ros1 Inhibitor Synthetic Lethality in Breast Cancer

Cancer Discovery
Oncology
2018English

MT1-MMP: Endosomal Delivery Drives Breast Cancer Metastasis

Journal of Cell Biology
MedicineCell Biology
2015English

How Cancer Genomics Drives Cancer Biology: Does Synthetic Lethality Explain Mutually Exclusive Oncogenic Mutations?

Cold Spring Harbor Symposia on Quantitative Biology
BiochemistryGeneticsMolecular Biology
2016English

TROAP Promotes Breast Cancer Proliferation and Metastasis

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

Glucocorticoid Receptor Activity Promotes Breast Cancer Metastasis

Cancer Discovery
Oncology
2019English

Kindlin-1 Promotes Pulmonary Breast Cancer Metastasis

Cancer Research
Cancer ResearchOncology
2018English

HER2-positive Breast Cancer With Brain Metastasis, Long Responder to Lapatinib Therapy

AboutOpen
2018English

Molecular Characterization of Breast Cancer CTCs Associated With Brain Metastasis

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy